Japan
· Delayed Price · Currency is JPY Hisamitsu Pharmaceutical Co. Statistics
Total Valuation
Hisamitsu Pharmaceutical Co. has a market cap or net worth of JPY 296.16 billion. The enterprise value is 176.89 billion.
| Market Cap | 296.16B |
| Enterprise Value | 176.89B |
Important Dates
The last earnings date was Thursday, October 10, 2024.
| Earnings Date | Oct 10, 2024 |
| Ex-Dividend Date | Feb 27, 2025 |
Share Statistics
Hisamitsu Pharmaceutical Co. has 73.34 million shares outstanding. The number of shares has decreased by -6.44% in one year.
| Shares Outstanding | 73.34M |
| Shares Change (YoY) | -6.44% |
| Shares Change (QoQ) | -1.06% |
| Owned by Insiders (%) | 0.73% |
| Owned by Institutions (%) | 43.50% |
| Float | 52.76M |
Valuation Ratios
The trailing PE ratio is 20.74 and the forward PE ratio is 17.87.
| PE Ratio | 20.74 |
| Forward PE | 17.87 |
| PS Ratio | 2.02 |
| PB Ratio | 1.08 |
| P/FCF Ratio | 943.18 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.87, with an EV/FCF ratio of 563.35.
| EV / Earnings | 12.07 |
| EV / Sales | 1.18 |
| EV / EBITDA | 8.87 |
| EV / EBIT | 12.42 |
| EV / FCF | 563.35 |
Financial Position
The company has a current ratio of 3.53, with a Debt / Equity ratio of 0.00.
| Current Ratio | 3.53 |
| Quick Ratio | 2.97 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | 3.56 |
| Interest Coverage | 510.30 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 54.43M |
| Profits Per Employee | 5.31M |
| Employee Count | 2,759 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.77% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -20.77% |
| 50-Day Moving Average | 3,989.06 |
| 200-Day Moving Average | 3,962.98 |
| Relative Strength Index (RSI) | 59.53 |
| Average Volume (20 Days) | 117,235 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Hisamitsu Pharmaceutical Co. had revenue of JPY 150.19 billion and earned 14.65 billion in profits. Earnings per share was 194.73.
| Revenue | 150.19B |
| Gross Profit | 84.73B |
| Operating Income | 13.78B |
| Pretax Income | 20.65B |
| Net Income | 14.65B |
| EBITDA | 19.47B |
| EBIT | 13.78B |
| Earnings Per Share (EPS) | 194.73 |
Balance Sheet
The company has 122.74 billion in cash and 1.12 billion in debt, giving a net cash position of 121.62 billion or 1,658.23 per share.
| Cash & Cash Equivalents | 122.74B |
| Total Debt | 1.12B |
| Net Cash | 121.62B |
| Net Cash Per Share | 1,658.23 |
| Equity (Book Value) | 275.92B |
| Book Value Per Share | 3,730.05 |
| Working Capital | 148.44B |
Cash Flow
In the last 12 months, operating cash flow was 18.59 billion and capital expenditures -18.28 billion, giving a free cash flow of 314.00 million.
| Operating Cash Flow | 18.59B |
| Capital Expenditures | -18.28B |
| Free Cash Flow | 314.00M |
| FCF Per Share | 4.28 |
Margins
| Gross Margin | n/a |
| Operating Margin | 9.17% |
| Pretax Margin | 13.75% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | 0.21% |
Dividends & Yields
This stock pays an annual dividend of 90.00, which amounts to a dividend yield of 2.23%.
| Dividend Per Share | 90.00 |
| Dividend Yield | 2.23% |
| Dividend Growth (YoY) | 3.24% |
| Years of Dividend Growth | 7 |
| Payout Ratio | n/a |
| Buyback Yield | 6.44% |
| Shareholder Yield | 8.67% |
| Earnings Yield | 4.82% |
| FCF Yield | 0.11% |
Stock Splits
The last stock split was on June 27, 2000. It was a forward split with a ratio of 2.
| Last Split Date | Jun 27, 2000 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |